Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Chronic Obstructive Pulmonary Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Chronic Obstructive Pulmonary Disease Projects
--Argenta Discovery Ltd.
--Alkermes Inc
--EpiGenesis Pharmaceuticals Inc
--Chiesi Farmaceutici S.p.A
--GlaxoSmithKline plc
--) Forest Laboratories Inc
--Milkhaus Laboratory, Inc.
--Laboratorios Almirall, S.A.
--NicOx S.A.
--Mitsubishi Tanabe Pharma Corporation
--Nycomed
--Novartis AG
--Pfizer Inc
--Otsuka Pharmaceutical Co., Ltd.
--SkyePharma Plc
--Schering-Plough Corp
--Teijin Pharma Limited
--Sosei Group Corporation
--Vectura Group plc.
--Theravance Inc

--Top Companies in early stage Chronic Obstructive Pulmonary Disease Projects
--Adenosine Therapeutics, LLC
--Abbott Laboratories
--Argenta Discovery Ltd.
--Aeolus Pharmaceuticals Inc
--AstraZeneca Plc
--Arriva Pharmaceuticals, Inc
--CyDex Pharmaceuticals, Inc.
--Chiesi Farmaceutici S.p.A
--GlaxoSmithKline plc
--EpiGenesis Pharmaceuticals Inc
--LigoCyte Pharmaceuticals, Inc.
--Laboratorios Salvat, S.A
--Orexo AB
--NeuroSearch A/S
--Quark Pharmaceuticals, Inc.
--Plexxikon Inc
--Silence Therapeutics plc
--erly SR Pharma plc)
--Sanofi-Aventis
--Vectura Group plc.
--TOPIGEN Pharmaceuticals Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View